Display options
Cite
Hill JW, Nemoto EM. N-acetyl proline-glycine-proline: implications for neurological disorders. Neural Regen Res. 2016;11(6):898-9doi: 10.4103/1673-5374.184478.
Hill, J. W., & Nemoto, E. M. (2016). N-acetyl proline-glycine-proline: implications for neurological disorders. Neural regeneration research, 11(6), 898-9. https://doi.org/10.4103/1673-5374.184478
Hill, Jeff W, and Nemoto, Edwin M. "N-acetyl proline-glycine-proline: implications for neurological disorders." Neural regeneration research vol. 11,6 (2016): 898-9. doi: https://doi.org/10.4103/1673-5374.184478
Hill JW, Nemoto EM. N-acetyl proline-glycine-proline: implications for neurological disorders. Neural Regen Res. 2016 Jun;11(6):898-9. doi: 10.4103/1673-5374.184478. PMID: 27482207; PMCID: PMC4962576.
Copy Download .nbib Format: NLM
Share it on

Neural Regen Res. 2016 Jun;11(6):898-9. doi: 10.4103/1673-5374.184478.

N-acetyl proline-glycine-proline: implications for neurological disorders.

Neural regeneration research

Jeff W Hill, Edwin M Nemoto

Affiliations

  1. Department of Neurosurgery, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

PMID: 27482207 PMCID: PMC4962576 DOI: 10.4103/1673-5374.184478

[No abstract available.]

References

  1. Biochim Biophys Acta. 2014 Sep;1839(9):826-36 - PubMed
  2. Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1306-16 - PubMed
  3. Nat Med. 2006 Mar;12(3):317-23 - PubMed
  4. Eur J Pharmacol. 2011 Oct 15;668(3):428-34 - PubMed
  5. Science. 2010 Oct 1;330(6000):90-4 - PubMed
  6. J Neuroinflammation. 2015 Nov 21;12:214 - PubMed
  7. Mol Pharmacol. 2005 Mar;67(3):757-65 - PubMed
  8. Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2769-75 - PubMed
  9. Mediators Inflamm. 2015;2015:620581 - PubMed
  10. J Immunol. 2008 Apr 15;180(8):5662-9 - PubMed
  11. J Cereb Blood Flow Metab. 2010 Mar;30(3):459-73 - PubMed
  12. PLoS One. 2011 Jan 13;6(1):e15781 - PubMed
  13. Sci Adv. 2015;1(3):null - PubMed
  14. Invest Ophthalmol Vis Sci. 1998 Aug;39(9):1744-50 - PubMed

Publication Types